Jian, Y., Chang, L., Minxia, S., Sun, Y., Chu, X., Xue, H., Huang, W., Shen, X., Ma, J., Jia, G., Feng, Y., Xi, Z., Zhao, Y., Ma, Y., Xiao, J., Ma, G., Wang, Q., Bao, L., Dong, Y., Zhou, H., Sun, C., Su, G., Yan, Y., Qimuge, S., Su, L., Sun, J., Tian, W., Sun, X. L., Jing, H., Gao, D., Zhu, H., Chen, W., Li, J., Gao, W. (2025). Updated survival outcomes of pomalidomide/bortezomib/dexamethasone in newly diagnosed multiple myeloma with renal impairment: A prospective, open-label, multicenter, phase 2 study. Blood. https://doi.org/10.1182/blood-2025-5818